Last update :
18/04/2024
InfoStab
Infostab
List of drugs
List of drugs
Summary lists
Summary lists
Search for compatibilities
Search for compatibilities
Y-site compatibility table
Y-site compatibility table
References
References
Research teams
Research teams
Valistab
Valistab
Poster
Poster
Links
Links
Sponsors
Sponsors
Authors
Authors
User’s guide
User’s guide
Newsletter
Newsletter
References   References 2295  
Type : Manufacturer
Research teams :
Authors :
Title : Fosaprepitant (Emend®) - Summary of Product Characteristics
Reference : Merck Sharp Dohme 2013
Level of Evidence : 
Manufacturer's stability data
Physical stability : 
Chemical stability : 
Other methods : 
Comments : 
List of drugs
InjectionCalcium chloride Electrolyte
Incompatible + InjectionFosaprepitant dimeglumine
InjectionCalcium glucoheptonate Electrolyte
Incompatible + InjectionFosaprepitant dimeglumine
InjectionCalcium gluconate Electrolyte
Incompatible + InjectionFosaprepitant dimeglumine
InjectionFolinate calcium Cytoprotective
Incompatible + InjectionFosaprepitant dimeglumine
InjectionFosaprepitant dimeglumine Antiemetic
Factors which affect stability Solvent Ringer’s lactate solution Induces Degradation
Incompatible + InjectionCalcium chloride
Incompatible + InjectionCalcium glucoheptonate
Incompatible + InjectionCalcium gluconate
Incompatible + InjectionFolinate calcium
Incompatible + InjectionLevofolinate calcium
Incompatible + InjectionMagnesium sulfate
Incompatible + Ringer’s lactate solution
InjectionLevofolinate calcium Cytoprotective
Incompatible + InjectionFosaprepitant dimeglumine
InjectionMagnesium sulfate Electrolyte
Incompatible + InjectionFosaprepitant dimeglumine
  Mentions Légales